Drugs / RAPAE01
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04128917 Comparator | Jan → Dec 2020 | Helicobacter pylori infectious disease | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RAPAE01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04128917 ↗ |
| Route | Oral | “RAPAE01/Clarithromycin/Amoxicillin BID peroral” NCT04128917 ↗ |